![SIGN_AWAY_CANCER_white SIGN_AWAY_CANCER_white](https://oraclehnc.org.uk/wp-content/uploads/2024/03/SIGN_AWAY_CANCER_white.webp)
Get Involved - Share The Word
It is one of few cancers with a vaccine. The HPV vaccine could prevent over 100,000 cancers by 2058.
HPV infections and cancers can be prevented
There are over 100+ strains of HPV and only around 12 of these strains are high risk and can in some cases cause cancer. There are other strains that cause genital warts which are also prevented by the HPV vaccine.
Both boys and girls can develop cancers caused by high-risk HPV infections when they grow up but only 56% girls and 52% boys were vaccinated in UK in 2022, lagging well behind other countries.
Sign the HPV Consent form, Sign Away Cancer.
HPV and its impact on cancers
Oracle Head and Neck Cancer UK and its partners want to raise awareness of the impact of the human papillomavirus on rising rates of associated cancer.
Infection with high risk human papillomavirus is responsible for an increasing number of new cancers identified in the head and neck area. It is also the leading cause of cancers in the cervix and anogenital areas: cervical cancer, anal cancer, penile cancer, vulva cancer, vaginal cancer.
- There are around 3,200 new cervical cancer cases in the UK every year, that's 9 new cases every day. About 99.7% are caused by high risk HPV infection earlier in life.
- Anal cancer incidence is projected to rise 14% between 2023-2025 in the UK. There are about 1,484 new diagnoses every year. 91% of cases are caused by high risk HPV infection.
- There are around 700 new penile cancer cases per year in the UK. 63% are caused by high risk HPV infection.
- There are more than 1,000 new vulva and vaginal cancers diagnosed per year in the UK. More than 70% are caused by high risk HPV infection.
High risk HPV infection is now the fastest growing risk factor and leading cause of Head and Neck cancers.
There are more than 3,300 new cases of Head and Neck cancers linked to high risk HPV infection per year in the UK. These are mostly oropharyngeal cancers (the tonsils, back of tongue, back roof of mouth and parts of throat).
Sign your child's HPV vaccine permission form to sign away cancer.
Rates of oropharyngeal cancer in men have now exceeded that of cervical cancer in women in the UK and the US.
The incidence of these cancers is growing at a rate of 30% per decade.
HPV cancers have doubled in the last two decades and it is one of fastest growing cancers in the UK.
It is one of few cancers with a vaccine.
Sign your child's HPV vaccine permission form to sign away cancer.
Find out more about the HPV vaccine here:
HPV vaccines with PortmanDentex
Mouth cancer figures (HPV mention)
Pre-Pandemic vaccine uptake in Girls
Vaccine uptake in UK Girls 2022
Vaccine uptake in UK Boys 2022
Vaccination uptake and coverage was initially very good across the UK but fell considerably during and since the COVID-19 pandemic. Pre-pandemic coverage in girls (2019) was 81% but is now just 56% (2022). The vaccine has only been offered to boys in UK since 2019 and uptake of this is only at 52% (2022)
The HPV vaccine is currently available in schools for both boys and girls. This vaccine serves as a preventative measure against cancers associated with high-risk human papillomavirus (HPV). Importantly, it is offered free of charge and is strongly recommended for children aged 12 to 13. Additionally, there is a complimentary catch-up program for girls up to 25 years of age and boys (born after 1st September 2006) via all GPs.
This campaign was made possible through the generous support of Pemberton Asset Management, the amazing creative genius of Tiny Studios and the time of all the patients and clinicians who participated in the filming. Thank you so much for your help in getting this important message our there.
Follow us
Oracle Head and Neck Cancer UK is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS